• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Medtronic launches engagement program for diabetes patients

August 9, 2018 By Sarah Faulkner

MedtronicMedtronic (NYSE:MDT) said today that it launched its Inner Circle patient engagement program in the U.S.

The medtech titan’s program, which is designed for people living with diabetes, uses gamification to motivate and encourage its users to practice behaviors that help them control their blood sugar levels.

The Inner Circle program also gives users a place to form a community where they can challenge each other and track their progress.

Medtronic reported that the company was inspired to create the Inner Circle program when it learned that 88% of people using its MiniMed 670G automated insulin delivery system were interested in a program that could help boost their diabetes management.

Users will be invited to enroll in the program once they are on Medtronic’s 670G system or the Guardian Connect smart continuous glucose monitoring system, according to Medtronic.

“Diabetes is unrelenting, and we are committed to innovating in new ways – beyond technology – to provide inspiration, motivation and education to help people with diabetes on their journey to better health,” Louis Dias, chief patient officer for Medtronic’s diabetes business, said in prepared remarks. “As the leader in patient-centric care, we are working to enhance patients’ lives through the Medtronic Inner Circle program, which demonstrates our ongoing commitment to providing new and innovative offerings to people living with diabetes.”

“Our new therapies – such as the MiniMed 670G system – can help increase Time in Range and reduce hypoglycemic events,” Dr. Fran Kaufman, chief medical officer for Medtronic’s diabetes group, added. “This novel and innovative program gives patients tools and challenges them to improve their diabetes management and spend more Time in Range.”

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals, Wall Street Beat Tagged With: Medtronic

IN CASE YOU MISSED IT

  • Tandem Diabetes Care wins CE mark for Mobi insulin pump with Control-IQ+ technology
  • Glooko adds chief strategy officer to chief medical officer’s title
  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott
  • Study links Abbott CGM use to lower risk of hospitalizations due to heart complications

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS